Oyama, Takashi
Matsuda, Kensuke
Honda, Akira
Maki, Hiroaki
Masamoto, Yosuke
Murakami, Daisuke
Toya, Takashi
Sakurai, Masatoshi
Kataoka, Keisuke
Doki, Noriko
Kurokawa, Mineo https://orcid.org/0000-0002-4034-2422
Article History
Received: 11 October 2021
Revised: 11 October 2022
Accepted: 11 October 2022
First Online: 17 October 2022
Declarations
:
: TT and ND have received payment for lectures from Novartis Pharma K.K. KK has received research grants form Shionogi Pharma Co., Ltd., and payment for lectures from Astellas Pharma Inc., Novartis Pharma K.K., and Pfizer Inc. MK has received payment for lectures and research grants form from Astellas Pharma Inc. and Pfizer Inc., and research grants from Shionogi Pharma Co., Ltd. This is not related to the current study. The other authors declare no competing financial interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.